Literature DB >> 12205332

Faecal calprotectin: a bright future for assessing disease activity in Crohn's disease.

D R Gaya, J F Mackenzie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12205332     DOI: 10.1093/qjmed/95.9.557

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


× No keyword cloud information.
  5 in total

1.  Probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFM® modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderly.

Authors:  Sampo J Lahtinen; Sofia Forssten; Juhani Aakko; Linda Granlund; Nina Rautonen; Seppo Salminen; Matti Viitanen; Arthur C Ouwehand
Journal:  Age (Dordr)       Date:  2011-01-25

2.  The level of faecal calprotectin as a noninvasive biomarker of mucosal healing in children with ulcerative colitis.

Authors:  Edyta Szymańska; Monika Meglicka; Maciej Dądalski; Marcin Osiecki; Marta Kotkowicz-Szczur; Małgorzata Matuszczyk; Jarosław Kierkuś
Journal:  Prz Gastroenterol       Date:  2020-12-10

3.  Calprotectin as a diagnostic tool for inflammatory bowel diseases.

Authors:  Marianthi Chatzikonstantinou; Panagiotis Konstantopoulos; Spyros Stergiopoulos; Konstantinos Kontzoglou; Christos Verikokos; Despina Perrea; Dimitris Dimitroulis
Journal:  Biomed Rep       Date:  2016-09-07

4.  Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes.

Authors:  Andrea Vieira; Chia Bin Fang; Ernani Geraldo Rolim; Wilmar Artur Klug; Flávio Steinwurz; Lucio Giovanni Battista Rossini; Paulo Azevedo Candelária
Journal:  BMC Res Notes       Date:  2009-10-29

5.  Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases.

Authors:  A Damms; S C Bischoff
Journal:  Int J Colorectal Dis       Date:  2008-07-16       Impact factor: 2.571

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.